Skip to main content
Theralase Technologies Inc. logo

Theralase Technologies Inc. — Investor Relations & Filings

Ticker · TLT ISIN · CA88337V1004 LEI · 529900NI3Y8GLE2IBF28 TSXV Manufacturing
Open in API
Filings indexed 698 across all filing types
Latest filing 2022-04-30 Regulatory Filings
Country CA Canada
Listing TSXV TLT

About Theralase Technologies Inc.

https://theralase.com/

Theralase Technologies Inc. designs, develops, manufactures, and markets patented laser technology platforms for both bio-stimulative and bio-destructive medical applications. The company operates two core divisions. The first is Cool Laser Therapy (CLT), which utilizes proprietary super-pulsed laser systems for therapeutic purposes, focusing on pain management, inflammation reduction, tissue repair, and the effective elimination of chronic knee pain. The second is Anti-Cancer Therapy (ACT), which employs patented light-activated Photo Dynamic Compounds (PDCs) combined with laser technology for destructive applications, specifically targeting the safe and effective destruction of cancer, bacteria, and viruses.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification form titled 'Form 52-109FV1 Certification of annual filings - venture issuer basic certificate' signed by the Interim CEO of Theralase Technologies Inc. It certifies the review and fair presentation of the annual filings for the financial year ended December 31, 2021. The content is primarily an officer certification regarding the annual filings, not the filings themselves. It explicitly states it is a certification and does not include the actual financial statements or detailed report content. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the Annual Report (10-K) or other financial reports. The document length is short (3226 characters), and it is a certification letter rather than a full report or announcement of a report publication. Therefore, the correct classification is Regulatory Filings (RNS).
2022-04-30 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification form titled 'Form 52-109FV1 Certification of annual filings - venture issuer basic certificate' signed by the CFO of Theralase Technologies Inc. It certifies the review and fair presentation of the annual filings for the financial year ended December 31, 2021. The document explicitly states it is a certification related to annual filings, not the filings themselves. It does not contain financial statements or substantive financial data but is an attestation by an officer. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the actual annual report or financial report. The document length is short (3143 characters), and it is a certification letter, not the report itself.
2022-04-30 English
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management's Discussion and Analysis of Financial Condition and Operations' (MD&A) for Theralase Technologies Inc. It references the audited consolidated financial statements for the year ended December 31, 2021, and is prepared as of April 28, 2022. The content includes detailed discussion of business operations, forward-looking statements, leadership changes, COVID-19 impacts, and clinical study progress. The MD&A is a management report explaining financial results, business trends, and outlook, which aligns with the definition of Management Reports (MDA). The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement. Therefore, the appropriate classification is Management Reports (MDA).
2022-04-30 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Management Certification related to Form 13-502F1, which is a regulatory filing submitted to the Ontario Securities Commission concerning participation fees for reporting issuers. It contains officer certification statements, market value calculations, and fee details but does not include financial statements or substantive financial data typical of financial reports. The primary purpose is to certify the accuracy of the information provided in the form, which aligns with officer certification filings. Therefore, this document fits the Regulatory Filings (RNS) category rather than a full financial report or other specific filing types.
2022-04-30 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 13-501F1 related to participation fees for reporting issuers, including a management certification by the CFO. It contains detailed calculations of market values of securities over specified trading periods and the resulting participation fee payable. The document is a regulatory form submission with officer certification and financial data related to fees, not a financial report like an annual or interim report. It is primarily a certification and fee calculation form submitted to a securities commission, fitting the description of a Regulatory Filing (RNS) rather than a full financial report or other specific filing types.
2022-04-30 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 100% confidence The document is titled 'Independent Auditor's Report' and contains detailed audit opinion language, including the auditor's opinion on the consolidated financial statements of Theralase Technologies Inc. for the years ended December 31, 2021 and 2020. It includes references to IFRS, audit standards, management responsibilities, and detailed financial statements such as consolidated statements of financial position, operations, and cash flows. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The content matches the characteristics of a standalone audit report rather than a full annual report or other filing types. Therefore, the document should be classified as an Audit Report / Information (AR). FY 2021
2022-04-30 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.